In glioblastoma cells, NETs-derived high mobility group protein 1 (HMGB1) bound to receptor for advanced glycation endproducts (RAGE) and upregulated the NF-κB signaling in tumor cells [60]. This evidence concerns the gene NFKB1 and neoplasm.